Source: AbelsonTaylor Blog

AbelsonTaylor Blog AT Perspectives: How are digital therapeutics and telemedicine transforming DTC engagement?

In what ways are digital therapeutics and telemedicine transforming how pharmaceutical companies engage with patients, especially in direct-to-consumer marketing? The primary changes introduced with digital therapeutics and telemedicine are advances in personalized patient care, access to the right patients at the right time with more tailored messages, and patient access to care. Both technologies profoundly...The post AT Perspectives: How are digital therapeutics and telemedicine transforming DTC engagement? appeared first on AbelsonTaylor.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Dale Taylor's photo - President & CEO of AbelsonTaylor

President & CEO

Dale Taylor

CEO Approval Rating

85/100

Read more